Log in to save to my catalogue

Use of Nonclonal Serum Immunoglobulin Free Light Chains to Predict Overall Survival in the General P...

Use of Nonclonal Serum Immunoglobulin Free Light Chains to Predict Overall Survival in the General P...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3538473

Use of Nonclonal Serum Immunoglobulin Free Light Chains to Predict Overall Survival in the General Population

About this item

Full title

Use of Nonclonal Serum Immunoglobulin Free Light Chains to Predict Overall Survival in the General Population

Publisher

Rochester, MN: Elsevier Inc

Journal title

Mayo Clinic proceedings, 2012-06, Vol.87 (6), p.517-523

Language

English

Formats

Publication information

Publisher

Rochester, MN: Elsevier Inc

More information

Scope and Contents

Contents

Abstract Objective To determine whether the free light chain (FLC) assay provides prognostic information relevant to the general population. Methods After excluding persons with a known plasma cell disorder, we studied 15,859 Olmsted County, Minnesota, residents 50 years or older in whom unmasked data and samples for FLC testing were available. Bas...

Alternative Titles

Full title

Use of Nonclonal Serum Immunoglobulin Free Light Chains to Predict Overall Survival in the General Population

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3538473

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3538473

Other Identifiers

ISSN

0025-6196

E-ISSN

1942-5546

DOI

10.1016/j.mayocp.2012.03.009

How to access this item